048260 — OsstemImplant Co Share Price
0.000.00%
Last trade - 00:00- KR₩3tn
- KR₩3tn
- KR₩1tn
- 98
- 29
- 100
- 92
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 12.99 | ||
| PEG Ratio (f) | 0.62 | ||
| EPS Growth (f) | 26.61% | ||
| Dividend Yield (f) | 0.16% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 6.34 | ||
| Price to Tang. Book | 6.5 | ||
| Price to Free Cashflow | 44.71 | ||
| Price to Sales | 2.49 | ||
| EV to EBITDA | 9.76 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 43.19% | ||
| Return on Equity | 49.51% | ||
| Operating Margin | 22.97% | ||
Financial Summary
| Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | KR₩m | 460,146.87 | 565,042.6 | 631,596.21 | 824,565.66 | 1,053,472.24 | 1,207,550 | 1,405,350 | 21.5% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +22.94 | n/a | n/a | -78.46 | +482.05 | +37.31 | +20.73 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
OsstemImplant Co Ltd is a Korea-based company engaged in the manufacture and marketing of dental implants and software. The Company provides dental implants, including TS system type, SS system type, US system type, MS type, orthodontic screws and others under the brand name Osstem, as well as surgical kits and tools. It also imports and sells dental equipment; provides dental implant training and other courses under the brand name of AIC, and sells dental related books. The Company operates its businesses in domestic market and overseas markets such as America, Germany, China, Taiwan, Hong Kong, Singapore, Thailand, India and Russia, among others.
Directors
- Tae Gwan Uhm CEO (53)
- Yil Gyu Lee CFO (48)
- Jeong Gon Kim OTH (52)
- Byeong Jeom Moon OTH (50)
- Sang Guk Han OTH (67)
- Bong Seon Kim OTH (51)
- Gwang Hui Lee OTH (53)
- Jae Yong Shin OTH (62)
- Nong Mun Hwang NID (55)
- Hae Sin Lee NID (39)
- Yong Mu Lee NID (46)
- Last Annual
- December 31st, 2022
- Last Interim
- March 31st, 2023
- Incorporated
- January 8th, 1997
- Public Since
- February 7th, 2007
- No. of Shareholders
- 37,494
- No. of Employees
- 1,031
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Korea Exchange - KOSDAQ
- Shares in Issue
- 1,463,701.1
- Address
- 3, Magokjungang 12-ro, Gangseo-gu, SEOUL, 07789
- Web
- https://www.osstem.com/
- Phone
- +82 220167000
- Auditors
- Ihnduck Accounting Corp.
Upcoming Events for 048260
Similar to 048260
Access Bio
Korea Exchange - KOSDAQ
Aligned Genetics
Korea Exchange - KOSDAQ
Asta Co
Korea Exchange - KOSDAQ
Biodyne Co
Korea Exchange - KOSDAQ
Bistos Co
Korea Exchange - KOSDAQ
FAQ
What is the OsstemImplant Co share price?
As of Today at 19:17 UTC, shares in OsstemImplant Co are trading at KR₩1,880,000. This share price information is delayed by 15 minutes.
How has the OsstemImplant Co share price performed this year?
Shares in OsstemImplant Co last closed at KR₩1,880,000 and the price had moved by +1732.36% over the past 365 days. In terms of relative price strength the OsstemImplant Co share price has outperformed the FTSE Developed Asia Pacific Index by +1644.13% over the past year.
What are the analyst and broker recommendations for OsstemImplant Co?
The overall consensus recommendation for OsstemImplant Co is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the OsstemImplant Co dividend yield?
OsstemImplant Co does not currently pay a dividend.
Does OsstemImplant Co pay a dividend?
OsstemImplant Co does not currently pay a dividend.
When does OsstemImplant Co next pay dividends?
OsstemImplant Co does not currently pay a dividend.
How do I buy OsstemImplant Co shares?
To buy shares in OsstemImplant Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of OsstemImplant Co?
As of the previous close price of KR₩1,880,000, shares in OsstemImplant Co had a market capitalisation of KR₩3tn.
Where are OsstemImplant Co shares listed?
Here are the trading details for OsstemImplant Co:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 048260
What kind of share is OsstemImplant Co?
Based on an overall assessment of its quality, value and momentum OsstemImplant Co is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a OsstemImplant Co share price forecast for 2023?
The analyst consensus target price for shares in OsstemImplant Co is KR₩1,990,000. That is 5.85% above the last closing price of KR₩1,880,000.
Analysts covering OsstemImplant Co currently have a consensus Earnings Per Share (EPS) forecast of KR₩129,455 for the next financial year.
What is the trend in the OsstemImplant Co share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like OsstemImplant Co. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +1326%.
As of the last closing price of KR₩1,880,000, shares in OsstemImplant Co were trading +1022.41% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the OsstemImplant Co PE Ratio?
The OsstemImplant Co PE ratio based on its reported earnings over the past 12 months is 12.99. The shares last closed at KR₩1,880,000.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of OsstemImplant Co?
OsstemImplant Co's management team is headed by:
- Tae Gwan Uhm - CEO
- Yil Gyu Lee - CFO
- Jeong Gon Kim - OTH
- Byeong Jeom Moon - OTH
- Sang Guk Han - OTH
- Bong Seon Kim - OTH
- Gwang Hui Lee - OTH
- Jae Yong Shin - OTH
- Nong Mun Hwang - NID
- Hae Sin Lee - NID
- Yong Mu Lee - NID